Sangamo Therapeutics

In News

Sangamo Therapeutics (SGMO) Q4 Loss Highlights Deep TTM Deficit Challenging Bullish Profitability Hopes - simplywall.st

simplywall.st - Apr 01, 2026

Sangamo Therapeutics Q4 Earnings Call Highlights - finance.yahoo.com

finance.yahoo.com - Mar 31, 2026

If You Invested $1,000 in Sangamo Therapeutics Inc (SGMO) - Stock Titan

Stock Titan - Mar 22, 2026

Sangamo Therapeutics Faces Rising Trade Policy Risks, Higher Costs and Global Growth Uncertainty - TipRanks

TipRanks - Apr 01, 2026

Sangamo Therapeutics Inc (SGMO) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges - GuruFocus

GuruFocus - Mar 31, 2026

Sangamo Therapeutics (NASDAQ:SGMO) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS - MarketBeat

MarketBeat - Mar 30, 2026

Sangamo Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary - TradingView

TradingView - Mar 30, 2026

Press Release: Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results - Moomoo

Moomoo - Mar 30, 2026

Sangamo Therapeutics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Sahm

Sahm - Mar 30, 2026

Sangamo Therapeutics earnings missed by $0.10, revenue fell short of estimates - Investing.com

Investing.com - Mar 30, 2026

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call - finance.yahoo.com

finance.yahoo.com - Mar 19, 2026

Sangamo pushes Fabry gene therapy toward FDA as cash runway reaches Q3 - Stock Titan

Stock Titan - Mar 30, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment